Skip to main content
logo
Clover Biopharmaceuticals, Ltd. (HKG:2197)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.910
-0.085 (-4.26%)
Sep 11, 2026, 4:08 PM HKT

Clover Biopharmaceuticals Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2,4803,0373138043,34815,727
Market Cap Growth
1.68%871.54%-61.11%-75.99%-78.71%-
Enterprise Value
2,3652,61844-8978516,969
Last Close Price
1.912.340.240.622.5913.58

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-0.710.710.785.875.49
PS Ratio
4995.68778.627.6518.58--
PB Ratio
-2.68-1.52-0.18-0.99-4.4310.51
P/TBV Ratio
-----10.63

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-671.111.08---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.00-0.01-0.05-0.46-0.530.06
Net Debt / Equity Ratio
0.120.150.200.571.90-2.29
Net Debt / EBITDA Ratio
0.351.140.350.160.541.25
Net Debt / FCF Ratio
-1.391.130.570.722.86
Asset Turnover
0.000.010.030.01--
Inventory Turnover
0.750.022.011.110.300.16
Quick Ratio
0.570.170.250.360.571.33
Current Ratio
0.730.190.350.831.552.36
Return on Equity (ROE)
-----889.96%-5089.78%
Return on Assets (ROA)
-44.48%-25.07%-40.96%-47.84%-29.88%-42.83%
Return on Capital Employed (ROCE)
-476.30%19.70%87.20%1481.60%-128.70%-70.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
39.62%-7.51%-307.56%-18.99%-82.79%-46.96%
FCF Yield
--7.14%-98.60%-100.73%-59.70%-7.63%
Buyback Yield / Dilution
-1.58%-0.53%-0.82%-12.83%4.84%-52.85%